BioVie Inc.
BIVI
$1.97
-$0.10-4.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.81% | 11.14% | |||
| Depreciation & Amortization | -89.01% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.20% | -14.00% | |||
| Operating Income | -6.20% | 14.00% | |||
| Income Before Tax | -7.12% | 13.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.12% | 13.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.12% | 13.17% | |||
| EBIT | -6.20% | 14.00% | |||
| EBITDA | -7.23% | 14.13% | |||
| EPS Basic | -1.98% | 8.83% | |||
| Normalized Basic EPS | -1.97% | 8.83% | |||
| EPS Diluted | -1.77% | 9.09% | |||
| Normalized Diluted EPS | -1.97% | 8.83% | |||
| Average Basic Shares Outstanding | 5.05% | -4.76% | |||
| Average Diluted Shares Outstanding | 5.05% | -4.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||